Specsavers opens bookings for PAC 2026

When selecting patient-reported outcome measures for randomized controlled trials for AMD, it’s important to select tools that align with the target population and the functional domains that are most likely to change. For example, patient populations with intermediate or earlier AMD with preserved vision may require instruments that obtain low-luminance and contrast-related data or activity diffi